Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18963373 | PROXIMAL-FEMUR INTRAOSSEOUS RELEASE DEVICE | November 2024 | March 2025 | Allow | 4 | 1 | 0 | No | No |
| 18850758 | MANUAL CONTROL HANDHELD PRESSURE-ADJUSTABLE IRRIGATION AND SUCTION ELECTROCOAGULATION CUTTER | September 2024 | March 2025 | Allow | 6 | 0 | 0 | No | No |
| 18820142 | OPTHALMOLOGICAL MICROSURGERY INSTRUMENTATION SYSTEM AND METHODS OF USE FOR PARS PLANAR VITRECTOMY | August 2024 | November 2025 | Abandon | 14 | 1 | 1 | No | No |
| 18393582 | OPHTHALMOLOGICAL SURGERY MICROSURGERY INSTRUMENTS AND METHODS OF USE IN PARS PLANA VITRECTOMY FOR INCREASING SURGICAL PRECISION AND REDUCING VITREORETINAL INSTRUMENT INSERTIONS AND REMOVALS AND RELATED TRAUMA | December 2023 | November 2024 | Abandon | 11 | 0 | 1 | No | No |
| 18238298 | Blood Control for a Catheter Insertion Device | August 2023 | May 2025 | Allow | 20 | 0 | 0 | No | No |
| 18178728 | CONTROLLED FLOW DRUG DELIVERY IMPLANTABLE DEVICE | March 2023 | September 2023 | Allow | 6 | 1 | 0 | Yes | No |
| 18170835 | METHODS AND DEVICES FOR VASCULAR ACCESS | February 2023 | October 2025 | Allow | 32 | 1 | 0 | No | No |
| 18000925 | SYRINGE INJECTOR WITH A FEEDBACK MECHANISM | December 2022 | January 2024 | Abandon | 13 | 1 | 0 | No | No |
| 18052952 | FLUID DELIVERY DEVICE WITH HYDROPHOBIC SURFACE | November 2022 | October 2025 | Allow | 36 | 1 | 0 | No | No |
| 17937993 | INFUSION SET | October 2022 | July 2025 | Allow | 33 | 1 | 0 | No | No |
| 17939028 | HOLLOW NEEDLE FOR ACCESS IN NON-LINEAR PATH | September 2022 | December 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17893577 | OPHTHALMOLOGICAL SURGERY MICROSURGERY INSTRUMENTS AND METHODS OF USE IN PARS PLANA VITRECTOMY FOR INCREASING SURGICAL PRECISION AND REDUCING VITREORETINAL INSTRUMENT INSERTIONS AND REMOVALS AND RELATED TRAUMA | August 2022 | January 2024 | Abandon | 17 | 1 | 1 | No | No |
| 17888133 | SYSTEM AND METHOD FOR MICRODOSE INJECTION | August 2022 | October 2025 | Allow | 38 | 1 | 0 | No | No |
| 17879198 | ADJUSTABLE RATE DRUG DELIVERY IMPLANTABLE DEVICE | August 2022 | July 2025 | Abandon | 35 | 1 | 0 | Yes | No |
| 17866621 | OCULAR SURGICAL WORK TIP ADAPTER | July 2022 | April 2025 | Allow | 33 | 2 | 0 | No | No |
| 17758802 | EXTERNAL END DEVICE AND METHOD FOR ITS CONNECTION TO FLOW LINES | July 2022 | March 2026 | Allow | 44 | 1 | 0 | No | No |
| 17812397 | METHODS AND DEVICES FOR VASCULAR ACCESS | July 2022 | January 2023 | Allow | 6 | 1 | 0 | Yes | No |
| 17846416 | CATHETER SHEATH DEVICES AND METHODS OF OPERATING CATHETER SHEATH DEVICE | June 2022 | April 2024 | Allow | 22 | 1 | 0 | No | No |
| 17838881 | INTRAOSSEOUS DEVICE HAVING RETRACTABLE MOTOR/STYLET ASSEMBLY AND AUTOMATIC STYLET POINT COVER UPON RETRACTION OPERATION | June 2022 | November 2024 | Abandon | 29 | 2 | 0 | No | No |
| 17826799 | SELF-RIGHTING SYSTEMS AND RELATED COMPONENTS AND METHODS | May 2022 | February 2024 | Allow | 21 | 1 | 0 | Yes | No |
| 17704589 | MEDICATION INJECTION SYSTEM | March 2022 | April 2024 | Allow | 25 | 1 | 0 | No | No |
| 17702910 | MIDLINE CATHETER PLACEMENT DEVICE | March 2022 | July 2025 | Allow | 40 | 3 | 0 | No | No |
| 17669899 | Devices and Methods for Delivering Fluid to a Nasal Cavity | February 2022 | December 2024 | Allow | 34 | 1 | 0 | No | No |
| 17564388 | CATHETER SHEATH DEVICES AND METHODS OF OPERATING CATHETER SHEATH DEVICE | December 2021 | April 2022 | Allow | 4 | 0 | 0 | No | No |
| 17493570 | Transradial Sheath Support and Hemostasis Device and Method | October 2021 | April 2024 | Allow | 30 | 1 | 0 | No | No |
| 17480871 | UNIVERSAL THREAD FLUID CONTAINER ENCLOSURE SYSTEMS | September 2021 | March 2026 | Allow | 53 | 1 | 1 | Yes | No |
| 17474545 | Catheter Assembly With Angle Changing and Related Methods | September 2021 | May 2025 | Allow | 44 | 2 | 0 | No | No |
| 17469613 | Aspiration Apparatus for Intraosseous Access System | September 2021 | May 2025 | Allow | 44 | 2 | 1 | No | No |
| 17459408 | Drug Delivery Devices for Deployment in Genitourinary Sites | August 2021 | July 2025 | Abandon | 47 | 0 | 1 | No | No |
| 17405996 | Catheter Assembly Including Transitioning Lumens | August 2021 | April 2025 | Allow | 44 | 4 | 0 | No | No |
| 17429883 | MEDICAL DEVICE INSUFFLATION CONNECTION | August 2021 | August 2025 | Allow | 48 | 2 | 0 | Yes | No |
| 17361507 | MICRONEEDLE ELECTROPORATION DEVICE | June 2021 | October 2025 | Allow | 52 | 1 | 0 | No | No |
| 17311823 | INJECTION DEVICE | June 2021 | July 2025 | Abandon | 49 | 1 | 0 | No | No |
| 17322942 | METHOD FOR MANUFACTURING NUCLEIC ACID FILM AND APPARATUS FOR INJECTING MEDICINE USING NUCLEIC ACID FILM | May 2021 | March 2025 | Allow | 46 | 1 | 0 | Yes | No |
| 17323348 | POLYMER SYSTEM FOR SECURING IMPLANTS IN SYRINGE NEEDLES | May 2021 | October 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17317176 | DEVICES, SYSTEMS, AND METHODS FOR ANCHORING ACTUATION WIRES TO A STEERABLE INSTRUMENT | May 2021 | November 2025 | Allow | 54 | 3 | 0 | No | No |
| 17313277 | NOVEL TREATMENT OF DYSPHAGIA | May 2021 | August 2025 | Abandon | 51 | 1 | 0 | No | No |
| 17313790 | AUTOMATED ORAL COMPOUND ADMINISTRATION SYSTEM AND METHOD | May 2021 | February 2026 | Abandon | 58 | 2 | 1 | No | No |
| 17307630 | NEEDLELESS CONNECTOR WITH COMPRESSIBLE AND DEFLECTABLE VALVE | May 2021 | April 2024 | Allow | 35 | 1 | 1 | No | No |
| 17279415 | CONNECTOR | March 2021 | April 2024 | Allow | 37 | 1 | 0 | No | No |
| 17181808 | VIAL SUPPORTER FOR MEDICAMENT PUMP | February 2021 | February 2024 | Allow | 36 | 1 | 0 | Yes | No |
| 17164517 | DELIVERY DEVICE FOR BIOLOGIC MATERIAL | February 2021 | November 2024 | Abandon | 45 | 1 | 0 | No | No |
| 17259774 | FLUID PRODUCT INJECTION DEVICE | January 2021 | January 2025 | Allow | 48 | 1 | 0 | No | No |
| 17259606 | CATHETER | January 2021 | June 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17259783 | FLUID INJECTION DEVICE | January 2021 | January 2025 | Allow | 48 | 1 | 0 | No | No |
| 17147240 | RESPIRATORY CARE SYSTEM WITH ELECTRONIC INDICATOR | January 2021 | May 2025 | Allow | 52 | 2 | 0 | Yes | Yes |
| 17259227 | METHOD AND APPARATUS | January 2021 | November 2024 | Abandon | 46 | 1 | 1 | No | No |
| 17135571 | AGENT DELIVERY SYSTEMS AND METHODS OF USING THE SAME | December 2020 | May 2024 | Allow | 41 | 1 | 0 | No | No |
| 17131259 | COUPLING DEVICE | December 2020 | April 2023 | Abandon | 28 | 1 | 0 | No | No |
| 17127151 | PERI-VASCULAR TISSUE ABLATION CATHETERS | December 2020 | April 2024 | Allow | 40 | 1 | 0 | No | No |
| 17127588 | FLUSH INSTRUMENT WITH BLOOD EXPOSURE PROTECTION AND RELATED METHODS | December 2020 | February 2024 | Allow | 37 | 1 | 1 | No | No |
| 17123708 | AGENT DELIVERY DEVICE | December 2020 | March 2025 | Allow | 51 | 2 | 1 | No | No |
| 17116768 | MEDICAL DEVICE FOR TREATING A VEIN | December 2020 | October 2022 | Allow | 22 | 0 | 0 | No | No |
| 17085816 | SYSTEMS AND APPARATUS FOR DRIP RATE MEASUREMENT FOR MEDICAL FLUID ADMINISTRATION | October 2020 | October 2023 | Allow | 36 | 1 | 0 | No | No |
| 17044258 | VIBRATING CAPSULE FOR ENHANCING ABSORPTION OF INGESTED MEDICAMENTS | October 2020 | March 2026 | Allow | 60 | 5 | 1 | Yes | No |
| 17032059 | DEVICE AND METHODOLOGY FOR PREPARING SKIN FOR SELF-INJECTION | September 2020 | April 2023 | Abandon | 31 | 1 | 0 | No | No |
| 17018340 | DRIP CHAMBER ASSEMBLY | September 2020 | March 2026 | Allow | 60 | 7 | 0 | No | No |
| 17011676 | DEAD END CONTAINER AND CONTAINER ASSEMBLY WITH DEAD END CONTAINER | September 2020 | May 2025 | Allow | 56 | 4 | 0 | No | No |
| 16971432 | PERITONEAL DIALYSIS MACHINE | August 2020 | November 2024 | Abandon | 51 | 2 | 1 | No | No |
| 16992243 | Drive mechanism | August 2020 | April 2024 | Allow | 44 | 4 | 0 | Yes | No |
| 16962739 | AUTOMATIC INJECTION SYSTEM | July 2020 | December 2021 | Allow | 17 | 1 | 0 | Yes | No |
| 16958434 | DOSAGE MEASUREMENT SYSTEM | June 2020 | February 2026 | Allow | 60 | 5 | 1 | No | Yes |
| 16900792 | INFUSION SET | June 2020 | April 2023 | Allow | 34 | 1 | 1 | Yes | No |
| 16884802 | FLUID DELIVERY DEVICE WITH SENSOR | May 2020 | March 2023 | Allow | 34 | 1 | 0 | No | No |
| 16875377 | Catheter Device System and Method of Use | May 2020 | April 2024 | Allow | 47 | 5 | 0 | Yes | No |
| 16760351 | Apparatus and Method for Intracranial Drug Injection | April 2020 | June 2023 | Allow | 37 | 2 | 0 | No | No |
| 16802778 | Devices and Methods for Delivering Fluid to a Nasal Cavity | February 2020 | October 2021 | Allow | 19 | 1 | 0 | No | No |
| 16642568 | Methods and Devices for Use in Treatment of Plantar Fasciitis and Fat Grafting | February 2020 | October 2023 | Allow | 44 | 1 | 1 | Yes | No |
| 16798153 | ASPIRATION AND INJECTION DEVICE | February 2020 | September 2023 | Allow | 43 | 2 | 0 | Yes | No |
| 16788839 | SALIVA SOLUTION METERING APPARATUS WITH DELIVERY TUBE RETAINING MOUTHPIECE | February 2020 | April 2023 | Allow | 38 | 2 | 0 | No | No |
| 16787077 | TAKE-HOME DRUG DELIVERY SYSTEM | February 2020 | May 2025 | Allow | 60 | 6 | 0 | Yes | No |
| 16777248 | CATHETER SHEATH DEVICES AND METHODS OF OPERATING CATHETER SHEATH DEVICE | January 2020 | December 2021 | Allow | 22 | 1 | 0 | Yes | No |
| 16775749 | AUTOMATIC DRUG DELIVERY DEVICE | January 2020 | October 2022 | Allow | 33 | 1 | 0 | No | No |
| 16632822 | TIP FOR INTRA-TYMPANIC INJECTION | January 2020 | April 2023 | Allow | 38 | 2 | 0 | Yes | No |
| 16630656 | APPARATUS AND METHOD FOR OPENING AND CLOSING AN INFUSION TUBE CLAMP | January 2020 | April 2024 | Allow | 51 | 2 | 1 | Yes | No |
| 16729205 | LIQUID MEDICINE INJECTION DEVICE | December 2019 | April 2023 | Allow | 40 | 1 | 0 | No | No |
| 16722177 | Large Bore Enteral Connector | December 2019 | April 2024 | Allow | 52 | 3 | 0 | Yes | No |
| 16696844 | Blood Control for a Catheter Insertion Device | November 2019 | April 2023 | Allow | 41 | 1 | 0 | No | No |
| 16694267 | SYSTEMS AND METHODS FOR ENHANCING UPTAKE OF THERAPEUTIC AGENT FROM BLOODSTREAM INTO DISEASE SITE | November 2019 | April 2023 | Abandon | 41 | 1 | 0 | No | No |
| 16691579 | SELF-RIGHTING SYSTEMS AND RELATED COMPONENTS AND METHODS | November 2019 | October 2022 | Allow | 35 | 1 | 0 | No | No |
| 16690086 | DRUG DELIVERY DEVICE WITH DOSE KNOB CLUTCH | November 2019 | January 2024 | Allow | 49 | 2 | 0 | No | No |
| 16687664 | Systems and Methods Related to Syringes | November 2019 | January 2024 | Allow | 50 | 3 | 0 | Yes | No |
| 16613766 | SELF-RIGHTING SYSTEMS AND RELATED COMPONENTS AND METHODS | November 2019 | October 2021 | Allow | 23 | 2 | 0 | Yes | No |
| 16683126 | SYSTEM AND METHOD FOR MICRODOSE INJECTION | November 2019 | March 2022 | Allow | 29 | 1 | 0 | No | No |
| 16594390 | FLUID DELIVERY DEVICE WITH HYDROPHOBIC SURFACE | October 2019 | October 2022 | Allow | 36 | 1 | 0 | Yes | No |
| 16500608 | SYRINGE TYPE EJECTION DEVICE | October 2019 | January 2023 | Allow | 39 | 2 | 0 | No | No |
| 16586275 | SURFACE MODIFICATION METHOD AND GASKET FOR SYRINGE | September 2019 | January 2024 | Abandon | 51 | 2 | 1 | No | No |
| 16566880 | ADAPTER FOR SINGLE-HANDED OPERATION OF SYRINGE DURING ASPIRATION OPERATION | September 2019 | October 2022 | Allow | 37 | 2 | 0 | Yes | No |
| 16564736 | Plunger for Syringes and Syringes | September 2019 | November 2024 | Allow | 60 | 3 | 0 | Yes | No |
| 16489243 | MIDLINE CATHETER PLACEMENT DEVICE | August 2019 | November 2021 | Allow | 27 | 1 | 0 | No | No |
| 16545953 | INTEGRATED PERIPHERAL INTRA-VENOUS CATHETER WITH IMPROVED EXTENSION TUBE PORT PROBE ACCESS | August 2019 | June 2023 | Allow | 46 | 2 | 0 | Yes | No |
| 16525477 | ADJUSTABLE RATE DRUG DELIVERY IMPLANTABLE DEVICE | July 2019 | April 2022 | Allow | 33 | 1 | 0 | Yes | No |
| 16479510 | AUTO-INJECTOR DEVICE | July 2019 | March 2020 | Allow | 8 | 1 | 0 | Yes | No |
| 16473247 | STEERABLE CATHETER SUITABLE FOR LEFT-HAND OPERATION | June 2019 | September 2023 | Allow | 51 | 3 | 1 | No | No |
| 16447684 | CATHETER SECUREMENT, STABILIZATION, AND ANTI-MICROBIAL DEVICE | June 2019 | October 2022 | Allow | 40 | 4 | 0 | Yes | No |
| 16438857 | SEALING CONTAINER | June 2019 | October 2022 | Allow | 40 | 1 | 0 | No | No |
| 16466505 | NEEDLE SHIELD REMOVAL MECHANISM FOR INJECTION DEVICE | June 2019 | April 2022 | Allow | 34 | 3 | 0 | Yes | No |
| 16344430 | MEDICAMENT INJECTION DEVICE | April 2019 | February 2022 | Allow | 33 | 2 | 0 | Yes | No |
| 16376821 | PASSIVE SAFETY INTRAOSSEOUS DEVICE | April 2019 | June 2022 | Allow | 39 | 0 | 0 | No | No |
| 16358707 | INTRAOSSEOUS DEVICE HAVING RETRACTABLE MOTOR/STYLET ASSEMBLY AND AUTOMATIC STYLET POINT COVER UPON RETRACTION OPERATION | March 2019 | March 2022 | Allow | 36 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner IGEL JR, MARK ALAN.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner IGEL JR, MARK ALAN works in Art Unit 3783 and has examined 178 patent applications in our dataset. With an allowance rate of 68.0%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 39 months.
Examiner IGEL JR, MARK ALAN's allowance rate of 68.0% places them in the 29% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by IGEL JR, MARK ALAN receive 1.93 office actions before reaching final disposition. This places the examiner in the 47% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by IGEL JR, MARK ALAN is 39 months. This places the examiner in the 28% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +35.2% benefit to allowance rate for applications examined by IGEL JR, MARK ALAN. This interview benefit is in the 83% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 31.5% of applications are subsequently allowed. This success rate is in the 65% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 36.5% of cases where such amendments are filed. This entry rate is in the 55% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 80.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 64% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 87.5% of appeals filed. This is in the 81% percentile among all examiners. Of these withdrawals, 57.1% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 76.9% are granted (fully or in part). This grant rate is in the 82% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.